The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 764-766

  Yoshida, Yoshio ^a   Kurokawa, Tetsuji ^a   Sawamura, Yoko ^a   Shinagawa, Akiko ^a   Okazawa, Hidehiko ^a   Fujibayashi, Yasuhisa ^a   Kotsuji, Fumikazu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Endocrine treatment; Endometrial cancer; FES PET

Indexed keywords

ESTRADIOL; FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CASE REPORT; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MEDICAL INFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33846921573     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.024     Document Type: Article

References (10)

1. Amant F., Neven P., Timmerman D., Van Limbergen E., and Vergote I. Endometrial cancer. Lancet 366 (2005) 491-505
2. Curtin J.P., Kavanagh J.J., Fox H., Spanos Jr. W.J., and Corpus. Mesenchymal tumors. In: William J.H., Carlos A.P., and Robert C.Y. (Eds). Principles and Practice of Gynecologic Oncology. 3rd ed. (1999), Lippincott Williams & Wilkins, Philadelphia 961-979
3. Pecorelli S., Fallo L., Sartori E., and Gastaldi A. Preinvasive lesions of the endometrium. Ann. N. Y. Acad. Sci. 622 (1991) 449-462
4. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat. Rev., Cancer 2 (2002) 683-693
5. Linden H.M., Stekhova S.A., Link J.M., Gralow J.R., Livingston R.B., Ellis G.K., et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J. Clin. Oncol. 24 (2006) 2793-2799
6. Randall T.C., and Kurman R.J. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet. Gynecol. 90 (1997) 434-440
7. Podratz K.C.O., Brien P.C., Malkasian G.D., Decker Jr. D.G., and Jefferies J.A. Effects of progestational agents in treatment of endometrial carcinoma. Obstet. Gynecol. 66 (1985) 106-110
8. Kumar R., and Alavi A. PET imaging in gynecologic malignancies. Radiol. Clin. North Am. 42 (2004) 1155-1167
9. Lerman H., Metser U., Grisaru D., Fishman A., Kievshitz G., and Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J. Nucl. Med. 45 (2004) 266-271
10. Habiba M.A., Bell S.C., and Al-Azzawi F. The effect of hormone replacement therapy on the immunoreactive concentrations in the endometrium of oestrogen and progesterone receptor, heat shock protein 27, and human beta-lactoglobulin. Hum. Reprod. 15 (2000) 36-42